{
    "clinical_study": {
        "@rank": "110816", 
        "arm_group": [
            {
                "arm_group_label": "NB-UVB phototherapy", 
                "arm_group_type": "Placebo Comparator", 
                "description": "NB-UVB alone"
            }, 
            {
                "arm_group_label": "phototherapy and photochemotherapy", 
                "arm_group_type": "Experimental", 
                "description": "NB-UVB and PUVA"
            }
        ], 
        "brief_summary": {
            "textblock": "To evaluate if the combination of psoralen plus ultraviolet A and narrowband ultraviolet B\n      is more effective than narrowband ultraviolet B alone in the treatment of vitiligo."
        }, 
        "brief_title": "NB-UVB and PUVA Vitiligo Study", 
        "condition": "Vitiligo", 
        "condition_browse": {
            "mesh_term": "Vitiligo"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Vitiligo affecting more than 15% body surface area."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 13, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01732965", 
            "org_study_id": "HFHS Vitiligo Phototherapy"
        }, 
        "intervention": [
            {
                "arm_group_label": "NB-UVB phototherapy", 
                "intervention_name": "Phototherapy", 
                "intervention_type": "Other"
            }, 
            {
                "arm_group_label": "phototherapy and photochemotherapy", 
                "intervention_name": "Phototherapy and Photochemotherapy", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Vitiligo", 
            "Phototherapy", 
            "Photochemotherapy"
        ], 
        "lastchanged_date": "March 27, 2013", 
        "location": {
            "contact": {
                "email": "pisedeh1@hfhs.org", 
                "last_name": "Prescilia Isedeh, MD", 
                "phone": "313-916-6964"
            }, 
            "facility": {
                "address": {
                    "city": "Detroit", 
                    "country": "United States", 
                    "state": "Michigan", 
                    "zip": "48202"
                }, 
                "name": "Henry Ford Dermatology"
            }, 
            "investigator": {
                "last_name": "Iltefat Hamzavi, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prospective Open Parallel Right to Left Bilateral Study Comparing Narrowband Ultraviolet B Alone Versus Narrowband Ultraviolet B and Psoralen Plus Ultraviolet A for the Treatment of Vitiligo", 
        "overall_contact": {
            "email": "pisedeh1@hfhs.org", 
            "last_name": "Prescilia Isedeh, MD", 
            "phone": "313-916-6964"
        }, 
        "overall_contact_backup": {
            "email": "vreeder1@hfhs.org", 
            "last_name": "Virginia Reeder, MD", 
            "phone": "313-916-6964"
        }, 
        "overall_official": {
            "affiliation": "Henry Ford Dermatology", 
            "last_name": "Iltefat Hamzavi, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Determination the degree of repigmentation measured by the VASI score (Vitiligo area Scoring Index) after treating with the combination treatments (narrowband ultraviolet B and topical psoralen plus ultraviolet A) and compare it with narrowband ultraviolet B alone.", 
            "measure": "Determine the quantity of repigmentation", 
            "safety_issue": "No", 
            "time_frame": "6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01732965"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Henry Ford Health System", 
            "investigator_full_name": "Iltefat Hamzavi", 
            "investigator_title": "Senior Staff Physician", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Determination of the color of repigmentation, pattern of repigmentation, and the cessation of spread of vitiligo after treating with the combination treatments (narrowband ultraviolet B and topical psoralen plus ultraviolet A) and compare it with narrowband ultraviolet B alone.", 
            "measure": "Determine the quality of repigmentation.", 
            "safety_issue": "No", 
            "time_frame": "Study initiation, 3 months and 6 months."
        }, 
        "source": "Henry Ford Health System", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Henry Ford Health System", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}